Jason Shand Robins - 20 Jan 2026 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Interim CFO
Signature
/s/ Todd Anderman, Attorney-in-Fact for Jason Shand Robins
Issuer symbol
OCUL
Transactions as of
20 Jan 2026
Net transactions value
$0
Form type
4
Filing time
22 Jan 2026, 18:41:16 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Robins Jason Shand Interim CFO C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD /s/ Todd Anderman, Attorney-in-Fact for Jason Shand Robins 22 Jan 2026 0002104600

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +33,000 $0.000000 33,000 20 Jan 2026 Common Stock 33,000 $11.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.